Phreesia Swings to Profit on Strong Revenue Growth, Cost Controls

TL;DR

**PHR is finally turning a profit, indicating strong operational leverage and a potential buy signal for growth-oriented investors.**

AI Summary

Phreesia, Inc. reported a significant turnaround in its financial performance for the three and nine months ended October 31, 2025. For the three months, the company posted a net income of $4.271 million, a substantial improvement from a net loss of $14.403 million in the same period of 2024. Total revenues increased by 12.6% to $120.333 million from $106.800 million year-over-year, driven by growth across all segments: subscription and related services rose to $55.480 million from $49.363 million, payment processing fees increased to $27.422 million from $24.704 million, and network solutions grew to $37.431 million from $32.733 million. For the nine months, Phreesia achieved a net income of $1.011 million, a dramatic shift from a $52.137 million net loss in the prior year. Total revenues for the nine-month period reached $353.524 million, up from $310.132 million in 2024. Operating expenses decreased to $116.594 million for the three months ended October 31, 2025, from $120.643 million in the prior year, primarily due to reduced sales and marketing expenses, which fell to $24.148 million from $30.071 million. The company's cash and cash equivalents also increased to $106.371 million as of October 31, 2025, from $84.220 million at January 31, 2025.

Why It Matters

This turnaround signals Phreesia's ability to scale its operations profitably, which is crucial for investor confidence in the competitive healthcare technology sector. The significant reduction in sales and marketing expenses while still growing revenue suggests improved sales efficiency, a key metric for SaaS companies. For employees, a profitable company offers greater job security and potential for growth. Customers benefit from a more stable and innovative partner, especially as Phreesia integrates AI into its offerings. This performance could also put competitive pressure on rivals in the EHR and practice management space, potentially leading to further consolidation or innovation in the market.

Risk Assessment

Risk Level: medium — While Phreesia achieved profitability, the company operates in a 'highly competitive industry' and faces risks from 'cyber-attacks, data breaches or cybersecurity incidents' as highlighted in the filing. Furthermore, the 'AccessOne Acquisition' integration poses potential difficulties, costs, and time consumption, which could impact future financial performance despite current positive results.

Analyst Insight

Investors should consider initiating or increasing positions in PHR, given the strong swing to profitability and revenue growth. Monitor the integration of the AccessOne Acquisition and the company's ability to sustain reduced operating expenses while continuing to innovate with AI, as these will be key drivers for long-term value.

Financial Highlights

debt To Equity

0.03

revenue

$120.333M

operating Margin

N/A

total Assets

$423.472M

total Debt

$9.552M

net Income

$4.271M

eps

$0.07

gross Margin

N/A

cash Position

$106.371M

revenue Growth

+12.6%

Revenue Breakdown

Key Numbers

• $4.271M — Net Income (3 months) (Swung from a $14.403M loss in 2024 to a profit in 2025.)
• $1.011M — Net Income (9 months) (Dramatic improvement from a $52.137M loss in 2024.)
• $120.333M — Total Revenue (3 months) (Increased 12.6% from $106.800M in 2024.)
• $353.524M — Total Revenue (9 months) (Increased from $310.132M in 2024.)
• $24.148M — Sales and Marketing Expense (3 months) (Decreased from $30.071M in 2024, indicating improved efficiency.)
• $106.371M — Cash and Cash Equivalents (Increased from $84.220M at January 31, 2025.)
• 60,287,003 — Common Shares Outstanding (As of December 2, 2025.)
• $0.07 — Basic EPS (3 months) (Positive EPS compared to -$0.25 in 2024.)

Key Players & Entities

• Phreesia, Inc. (company) — registrant in 10-Q filing
• AccessOne Acquisition (company) — recent acquisition mentioned as a risk factor
• SEC (regulator) — U.S. Securities and Exchange Commission
• $4.271 million (dollar_amount) — net income for three months ended October 31, 2025
• $14.403 million (dollar_amount) — net loss for three months ended October 31, 2024
• $120.333 million (dollar_amount) — total revenues for three months ended October 31, 2025
• $106.800 million (dollar_amount) — total revenues for three months ended October 31, 2024
• $1.011 million (dollar_amount) — net income for nine months ended October 31, 2025
• $52.137 million (dollar_amount) — net loss for nine months ended October 31, 2024
• $106.371 million (dollar_amount) — cash and cash equivalents as of October 31, 2025

FAQ

Risk Factors

• Dependence on Key Customers [high — operational]: The company's revenue is concentrated among a significant number of customers. A substantial portion of revenue is derived from a limited number of clients, and the loss of any of these key customers could materially and adversely affect financial results. For example, the loss of a major client could lead to a significant drop in revenue and profitability.
• Healthcare Regulatory Compliance [high — regulatory]: Phreesia operates in the healthcare industry, which is subject to extensive and evolving federal and state regulations, including HIPAA. Non-compliance can result in significant penalties, reputational damage, and operational disruptions. The company must continually adapt to new regulations and ensure its platforms and processes meet stringent privacy and security standards.
• Competition and Technological Advancements [medium — market]: The digital health and patient engagement market is highly competitive and rapidly evolving. Phreesia faces competition from established players and new entrants. Failure to innovate and keep pace with technological advancements or to differentiate its offerings could lead to market share erosion and reduced revenue growth.
• Ability to Manage Growth and Profitability [medium — financial]: While the company has shown a recent turnaround to profitability, sustained growth and profitability depend on effectively managing operating expenses, including sales and marketing, and achieving economies of scale. A return to significant losses could impact investor confidence and access to capital.
• Data Security and Privacy Breaches [high — operational]: The company handles sensitive patient health information, making it a target for cyberattacks. A data breach could lead to significant financial losses, legal liabilities, regulatory fines, and severe damage to its reputation and customer trust. The cost of cybersecurity measures and potential breach remediation is substantial.
• Reliance on Third-Party Service Providers [medium — financial]: Phreesia relies on third-party vendors for various services, including cloud hosting and payment processing. Disruptions or failures in these services could impact the company's ability to operate and deliver its platform, potentially leading to revenue loss and customer dissatisfaction.

Industry Context

Phreesia operates in the competitive digital health and patient engagement technology sector. The industry is characterized by rapid technological advancements and a growing demand for solutions that improve patient experience, streamline administrative processes, and enhance data security within healthcare systems. Key trends include the increasing adoption of telehealth, the need for interoperability between different healthcare IT systems, and a strong focus on patient data privacy and regulatory compliance.

Regulatory Implications

As a healthcare technology provider, Phreesia is subject to stringent regulations like HIPAA, requiring robust data privacy and security measures. Non-compliance can lead to significant fines and reputational damage. The evolving regulatory landscape necessitates continuous investment in compliance and security infrastructure to mitigate risks and maintain customer trust.

What Investors Should Do

1. Monitor continued revenue growth across all segments, particularly the Network Solutions segment which showed the highest growth rate (14.3%) in the quarter.
2. Evaluate the sustainability of the reduced operating expenses, especially the significant decrease in Sales and Marketing, to ensure it doesn't hinder future growth.
3. Assess the company's ability to maintain profitability and manage its accumulated deficit, given the recent swing to net income.
4. Observe trends in cash and cash equivalents and working capital management, particularly the increase in cash to $106.371M.

Key Dates

• 2025-10-31: Quarter End — Reported net income of $4.271M and total revenues of $120.333M, a significant improvement from the prior year.
• 2025-10-31: Nine Months End — Achieved net income of $1.011M, a substantial turnaround from a net loss of $52.137M in the prior year.
• 2025-01-31: Fiscal Year End — Company had $84.220M in cash and cash equivalents.
• 2025-12-02: Common Shares Outstanding — Reported 60,287,003 common shares outstanding.

Glossary

Settlement assets / obligations

Assets and liabilities related to the processing of payments, where funds are held temporarily during the transaction lifecycle. (Represents funds in transit for payment processing, impacting working capital.)

Deferred contract acquisition costs

Costs incurred to obtain contracts with customers that are capitalized and amortized over the expected customer life. (Reflects the company's investment in acquiring new business, impacting profitability over time.)

Accumulated deficit

The total net losses of a company since its inception, less any net gains. (Indicates the company's historical profitability; a reduction signifies progress towards overall profitability.)

Deferred revenue

Revenue that has been paid for by customers but not yet earned by the company (e.g., for services to be rendered in the future). (Represents future revenue streams and impacts cash flow and revenue recognition.)

Capitalized internal-use software

Costs associated with developing software for internal use that are capitalized rather than expensed immediately. (Represents investment in technology infrastructure that supports operations.)

Goodwill

An intangible asset that arises when a company acquires another company for a price greater than the fair value of its net identifiable assets. (Represents the premium paid in acquisitions, indicating past strategic growth through M&A.)

Year-Over-Year Comparison

Phreesia has demonstrated a significant financial turnaround compared to the prior year. Total revenues for the three months ended October 31, 2025, increased by 12.6% to $120.333M, while net income swung from a $14.403M loss to a $4.271M profit. Operating expenses decreased, notably Sales and Marketing costs, contributing to improved efficiency. The company's cash position has also strengthened, rising from $84.220M at January 31, 2025, to $106.371M at October 31, 2025.

Key Financial Figures

• $0.01 — ich registered Common Stock, par value $0.01 per share PHR The New York Stock Exchan

Filing Documents

• phr-20251031.htm (10-Q) — 1827KB
• phr-20251031ex311.htm (EX-31.1) — 14KB
• phr-20251031ex312.htm (EX-31.2) — 14KB
• phr-20251031ex321.htm (EX-32.1) — 8KB
• phr-20251031ex322.htm (EX-32.2) — 8KB
• 0001412408-25-000132.txt ( ) — 9311KB
• phr-20251031.xsd (EX-101.SCH) — 61KB
• phr-20251031_cal.xml (EX-101.CAL) — 126KB
• phr-20251031_def.xml (EX-101.DEF) — 274KB
• phr-20251031_lab.xml (EX-101.LAB) — 786KB
• phr-20251031_pre.xml (EX-101.PRE) — 565KB
• phr-20251031_htm.xml (XML) — 1248KB

— FINANCIAL INFORMATION

PART I — FINANCIAL INFORMATION Item 1 .

Financial Statements

Financial Statements: Consolidated Balance Sheets as of Oc tober 31, 2025 (unaudited) and January 31, 2025 9 Consolidated Statements of Operations for the Three and Nine Months Ended October 31, 2025 and 2024 (unaudited) 10 Consolidated Statements of Comprehensive Loss for the Three and Nine Months Ended October 31, 2025 and 2024 (unaudited) 11 Consolidated Statements of Stockholders' Equity for the Three and Nine Months Ended October 31, 2025 and 2024 (unaudited) 12 Consolidated Statements of Cash Flows for the Three and Nine Months Ended October 31, 2025 and 2024 (unaudited) 14 Notes to Unaudited Consolidated Financial Statements 16

Management's Discussion and Analysis of Financial Condition and Results of Operations

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 37

Quantitative and Qualitative Disclosures About Market Risk

Item 3. Quantitative and Qualitative Disclosures About Market Risk 51

Controls and Procedures

Item 4. Controls and Procedures 52

— OTHER INFORMATION

PART II — OTHER INFORMATION

Legal Proceedings

Item 1. Legal Proceedings 53

Risk Factors

Item 1A. Risk Factors 53

Unregistered Sales of Equity Securities and Use of Proceeds

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 87

Defaults Upon Senior Securities

Item 3. Defaults Upon Senior Securities 87

Mine Safety Disclosures

Item 4. Mine Safety Disclosures 87

Other Information

Item 5. Other Information 87

Exhibits

Item 6. Exhibits 88

Signatures

Signatures 90 3 Table of Contents Summary of Material Risks Associated with our Business Our business is subject to numerous risks and uncertainties that you should be aware of in evaluating our business. These risks and uncertainties include, but are not limited to, the following: We operate in a highly competitive industry, and if we are not able to compete effectively, including with the electronic health records ("EHR") and practice management ("PM") systems with which we integrate, our business and results of operations may be harmed. If we fail to manage our future growth effectively, our revenue may not increase, and we may be unable to implement our business strategy. Our operating results have fluctuated and may continue to fluctuate significantly and if we fail to meet the expectations of analysts or investors, our stock price and the value of your investment could decline substantially. Privacy concerns, cyber-attacks, data breaches or cybersecurity incidents relating to our solutions could result in economic loss, damage to our reputation, deterring users from using our products, and our exposure to legal penalties and liability. Our operations in India subject us to additional risks which could have an adverse effect on our business, operating results, and financial condition . We typically incur significant upfront costs in our client relationships, and if we are unable to develop or grow these relationships over time, we are unlikely to recover these costs and our operating results may suffer. As a result of our variable sales and implementation cycles, we may be unable to recognize revenue to offset expenditures, which could result in fluctuations in our quarterly results of operations or otherwise harm our future operating results. The estimates and assumptions we use to determine the size of our target market may prove to be inaccurate, and even if the markets in which we compete meet our size estimates and forecasted growth, our bu

– FINANCIAL INFORMATION

PART I – FINANCIAL INFORMATION

FINANCIAL STATEMENTS

ITEM 1. FINANCIAL STATEMENTS Phreesia, Inc. Consolidated Balance Sheets (in thousands, except share and per share data) October 31, 2025 January 31, 2025 (Unaudited) Assets Current: Cash and cash equivalents $ 106,371 $ 84,220 Settlement assets 25,391 29,176 Accounts receivable, net of allowance for doubtful accounts of $ 2,175 and $ 1,468 as of October 31, 2025 and January 31, 2025, respectively 88,257 73,617 Deferred contract acquisition costs 427 401 Prepaid expenses and other current assets 20,460 15,871 Total current assets 240,906 203,285 Property and equipment, net of accumulated depreciation and amortization of $ 93,842 and $ 84,505 as of October 31, 2025 and January 31, 2025, respectively 21,111 23,651 Capitalized internal-use software, net of accumulated amortization of $ 65,681 and $ 55,991 as of October 31, 2025 and January 31, 2025, respectively 54,093 52,763 Operating lease right-of-use assets 820 1,477 Deferred contract acquisition costs 444 583 Intangible assets, net of accumulated amortization of $ 11,018 and $ 8,407 as of October 31, 2025 and January 31, 2025, respectively 25,532 28,143 Goodwill 75,845 75,845 Deferred tax asset 1,640 — Other assets 3,081 2,668 Total Assets $ 423,472 $ 388,415 Liabilities and Stockholders' Equity Current: Settlement obligations $ 25,391 $ 29,176 Current portion of finance lease liabilities and other debt 6,199 8,043 Current portion of operating lease liabilities 746 964 Accounts payable 6,218 5,622 Accrued expenses 30,517 37,460 Deferred revenue 29,712 32,758 Total current liabilities 98,783 114,023 Long-term finance lease liabilities and other debt 3,353 8,150 Operating lease liabilities, non-current 132 646 Long-term deferred revenue 151 119 Long-term deferred tax liabilities 683 484 Other long-term liabilities 41 185 Total Liabilities 103,143 123,607 Commitments and contingencies (Note 11) Stockholders' Equity: Preferred stock, undesignated, $ 0.01 par value— 20,000,

View Full Filing

View this 10-Q filing on SEC EDGAR